HM-03 (Helsinn Group)

N/A

Report date: 2025/03/20 15:14:41
NME

Base Information

Drug NameHM-03 (Helsinn Group)
Drug Alias Nameghrelin agonists (Helsinn Holding)ghrelin receptor agonist 2 (Helsinn Group)HM-03
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGhrelin/growth hormone secretagogue receptor agonists
TargetsGhrelin/growth hormone secretagogue receptor
Therapy Area/IndicationsFeeding and Eating DisordersCachexia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator Companies3B Future Health Fund
China Registration ClassN/A

Develop Information

Active Companies3B Future Health Fund
Inactive CompaniesN/A
Active IndicationsFeeding and Eating DisordersCachexia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A